Dabigatran Etexilate 110 mg/1 (Dabigatran Etexilate CAPSULE, COATED PELLETS) 110 mg/1

Dabigatran Etexilate 110 mg capsules are oral anticoagulants designed to help manage blood clotting. Learn about uses, effects, and precautions for this medication.

Strength

110 mg/1

Pack Size

6 BLISTER PACK in 1 CARTON (0904-7254-68) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0904-7254

Manufacturer / TM Owner

Major Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dabigatran Etexilate is commonly used as a blood thinner to prevent blood clots. It is often prescribed for conditions like atrial fibrillation or after certain surgeries to reduce the risk of stroke and blood clots. People often ask, 'What is Dabigatran Etexilate used for?' It is primarily used for managing conditions that require anticoagulation therapy.

Side Effects

Dabigatran Etexilate works by inhibiting thrombin, which helps to prevent blood clots from forming. Common effects may include bleeding more easily or taking longer to stop bleeding. Some users may experience nausea, stomach pain, or indigestion. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Handle Dabigatran Etexilate with care, as it can increase the risk of bleeding. Avoid activities that may cause injury while taking this medication. Store the capsules at room temperature, away from moisture and heat. Always follow the guidance of a healthcare professional regarding its use.

Avoid Interactions

Dabigatran Etexilate may interact with other medications, including blood thinners, NSAIDs, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol can also increase the risk of bleeding, so it should be consumed with caution.

Frequently Asked Questions

Dabigatran Etexilate is used to prevent blood clots in conditions like atrial fibrillation or after certain surgeries.

Store Dabigatran Etexilate at room temperature, away from moisture and heat.

Common effects may include increased bleeding, nausea, stomach pain, or indigestion.

Yes, it may interact with blood thinners, NSAIDs, and certain antibiotics. Always consult a healthcare provider.

Alcohol can increase the risk of bleeding, so it should be consumed with caution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.